Showing results (231-240 of 257) with videos related to

Sort By:
Pageof 26
Ethnicity & Disease|March 24, 2025
Psychological Factors and Prevalence of Diabetes and Prediabetes in a United States-Mexico Border CommunityJessica L McCurley, Jesus A Naranjo, Rebeca A Jiménez, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
An intravenous DNA-binding priming agent protects cell-free DNA and improves the sensitivity of liquid biopsiesShervin Tabrizi, Carmen Martin-Alonso, Kan Xiong, et al.
Infection and Immunity|February 10, 2018
Genetic Polymorphisms in Cytokine Genes in Colombian Patients with Ocular ToxoplasmosisC A Naranjo-Galvis, A de-la-Torre, L E Mantilla-Muriel, et al.
Rehabilitacion|June 9, 2026
[Unraveling the Phenotypes of Dyspnea and Leg Discomfort Symptoms During Exercise and Their Clinical Relevance: A Multicenter Real-Life Study in the Andean Region]M Orozco-Ramírez, A Ramírez-Sarmiento, L Vargas-Ramirez, et al.
Bone Marrow Transplantation|January 22, 2013
A pilot study of tandem high-dose chemotherapy with stem cell rescue as consolidation for high-risk neuroblastoma: Children's Oncology Group study ANBL00P1A E Seif, A Naranjo, D L Baker, et al.
British Journal of Cancer|June 3, 2015
Augmented expression of MYC and/or MYCN protein defines highly aggressive MYC-driven neuroblastoma: a Children's Oncology Group studyL L Wang, R Teshiba, N Ikegaki, et al.
Biotechnology and Bioengineering|November 15, 2021
Scalable, methanol-free manufacturing of the SARS-CoV-2 receptor-binding domain in engineered Komagataella phaffiiNeil C Dalvie, Andrew M Biedermann, Sergio A Rodriguez-Aponte, et al.
Biorxiv : the Preprint Server for Biology|April 21, 2021
Scalable, methanol-free manufacturing of the SARS-CoV-2 receptor binding domain in engineered <i>Komagataella phaffii</i>Neil C Dalvie, Andrew M Biedermann, Sergio A Rodriguez-Aponte, et al.
Transplantation Proceedings|September 1, 2009
Establishment of a pediatric liver transplantation program: experience with 100 transplantation proceduresR Ciria, J M Sánchez-Hidalgo, J Briceño, et al.
Human Vaccines & Immunotherapeutics|June 6, 2022
Antigen-adjuvant interactions, stability, and immunogenicity profiles of a SARS-CoV-2 receptor-binding domain (RBD) antigen formulated with aluminum salt and CpG adjuvantsSakshi Bajoria, Kawaljit Kaur, Ozan S Kumru, et al.
Pageof 26